Merck launches Saflutan in first European markets

September 4, 2009
Research and Development, Sales and Marketing Merck, ophthalmology

Merck's glaucoma drug Saflutan has been launched in the UK and Spain. The manufacturer says more launches are planned in …

Novartis swine-flu jab effective in single dose

September 3, 2009
Manufacturing and Production, Research and Development, Sales and Marketing Novartis, h1n1

A study of Novartis' pandemic swine-flu jab shows it is potentially protective after just one dose, which could help eke …

Pharmafocus expands into Europe

September 3, 2009
Research and Development, Sales and Marketing Europe

 The September issue of Pharmafocus marks a new stage in the publication’s development with an expanded monthly circulation that takes …

Merck unveils post-merger leadership team

September 3, 2009
Research and Development, Sales and Marketing MA, Merck

The make-up of Merck and Schering-Plough's new corporate entity became clearer this week. Referred to as the 'new Merck' and …

Pfizer shamed with $2.3bn fine for marketing fraud

September 3, 2009
Sales and Marketing Pfizer, US, illegal, off label prescribing

The US government has imposed a $2.3 billion fine on Pfizer for a string of offences including illegal off-label prescribing …

New cancer cases set to hit 17 million by 2020

September 2, 2009
Research and Development, Sales and Marketing Cancer, healthcare

The next ten years will see a 30% leap in the number of new cancer cases across the world, according …

UCB and Novartis expand alliance in Germany

September 1, 2009
Sales and Marketing Germany, Novartis, UCB

UCB and Novartis have extended their partnership in Germany with a new licensing deal for the cardiovascular and diabetes drug …

Shire goes for early approval in Gaucher disease

September 1, 2009
Research and Development, Sales and Marketing Gaucher's, Shire

Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …

Pradaxa data boosts Boehringer

September 1, 2009
Research and Development, Sales and Marketing Boehringer, Pradaxa

Boehringer Ingelheim has unveiled new positive data for its blood-thinner Pradaxa, showing it reduces the risk of stroke compared to …

Pfizer agrees price cut in Clinton deal

September 1, 2009
Research and Development, Sales and Marketing HIV, Pfizer, price cuts

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

Indian government accepts pro-patent report

September 1, 2009
Research and Development, Sales and Marketing Asia, India, patents

The government of India has accepted the findings of a report into its patent laws, which recommends maintaining a higher …

EU divided over patient information proposals

September 1, 2009
Sales and Marketing EFPIA, Europe, patient information

 Europe’s member states are at loggerheads over plans to relax current restrictions on pharma communicating with patients.The plans tabled by …

Basilea buoyed by sales increase

September 1, 2009
Research and Development, Sales and Marketing Basilea

Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …

JLL says it will fight Lonza’s Patheon bid

September 1, 2009
Manufacturing and Production JLL, Patheon

Lonza's attempt to buy Canadian contract manufacturer Patheon will not go unopposed by private equity group JLL, which has been …

Supply chain controls blamed for UK medicines shortage

August 27, 2009
Manufacturing and Production, Research and Development supply chain

Industry supply chain controls in the UK have overwhelmingly made medicines more difficult to source and have put patients risk, …

Americans doubt benefits of health reform

August 27, 2009
Research and Development, Sales and Marketing US, US healthcare, healthcare

Most Americans are satisfied with their existing medical arrangements, according to a survey by Thomson Reuters.The results seem to be …

NICE criticised for rejection of kidney cancer drugs

August 27, 2009
Research and Development, Sales and Marketing Kidney cancer, NICE, Nexavar

Three treatments for advanced kidney cancer have been rejected by NICE, sparking criticism from pharma companies and patient groups.The drugs …

Venezuela restates threat to seize Pfizer plant

August 27, 2009
Manufacturing and Production, Sales and Marketing Pfizer, South America

The wrangling over Pfizer's manufacturing facility in Venezuela is continuing, with a senior official reiterating a threat to seize control …

Novartis unveils new lab approach to boost research capacity

August 27, 2009
Research and Development Novartis, Switzerland

Novartis has unveiled a new research approach involving novel lab technology and flexible working, in the hope to speed its …

The Gateway to Local Adoption Series

Latest content